The BioFire FilmArray System requires a higher initial investment than standard-of-care testing methods—but the cost savings benefits of syndromic infectious disease diagnostics are substantial in the long run.
About Breann Jensen
This author has not written his bio yet.
But we are proud to say that Breann Jensen contributed 60 entries already.
Entries by Breann Jensen
The news media calls it flu season. But healthcare providers know it’s much more than that—it’s respiratory season, the time of year when several cold and influenza viruses circulate widely, filling doctors’ offices, urgent care clinics, and emergency rooms with miserable patients. And this year, COVID-19 is expected to greatly compound the misery for everyone.
What we don’t know about COVID-19 still outweighs what we do know, however, COVID-19 isn’t the first coronavirus to infect humans. Learn more about coronaviruses.
Epidemiologists have found themselves in the spotlight of the global COVID-19 pandemic as they race to trace and understand the novel virus.
Over 1.7 million people are diagnosed with sepsis in the US each year, yet more than 34% of Americans have never heard of sepsis. Learn the facts.
Systematic review and meta-analysis on the impact of molecular rapid diagnostic tests and the role syndromic panels can play in antimicrobial stewardship.
Polymerase chain reaction technology is at the heart of our mission here at BioFire: to provide syndromic infectious disease diagnostic solutions that help make the world a healthier place.
Learn how the BioFire GI Panel provides fast, comprehensive results in about an hour, while helping maximize the stool bench and improve patient care.
Foodborne illness outbreaks, from E. coli, Listeria, & Salmonella tend to hog the spotlight. But Cyclospora, also wreaks havoc in the summer. Learn more!
You may not want to become friends with a gastrointestinal bug—but there’s no holding in their affection for you! Thankfully, we can help you detect which GI bug is busy making a friendship bracelet especially for you.